Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic
2020; Lippincott Williams & Wilkins; Volume: 51; Issue: 6 Linguagem: Inglês
10.1161/strokeaha.120.030023
ISSN1524-4628
Tópico(s)Long-Term Effects of COVID-19
ResumoHomeStrokeVol. 51, No. 6Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic Free AccessReview ArticlePDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBTemporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) PandemicOn Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership On Behalf of the AHA/ASA Stroke Council Leadership On Behalf of the AHA/ASA Stroke Council Leadership From the Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA. Originally published1 Apr 2020https://doi.org/10.1161/STROKEAHA.120.030023Stroke. 2020;51:1910–1912Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: April 1, 2020: Ahead of Print During this unprecedented time of extraordinary stress on the US healthcare system, the American Heart Association/American Stroke Association Stroke Council—as individuals in our localities and together as an entity at the national level—acknowledge the mounting concern regarding optimal stroke care during the coronavirus disease 2019 (COVID-19) pandemic among vascular neurologists and those clinicians who care for stroke patients. We therefore seek to provide guidance for the care of stroke patients in the midst of the crisis. Ordinarily, national recommendations go through a rigorous process of development, refinement, peer review, and thoughtful promulgation. None of that is possible at this time, yet we think there is a substantial need for a broad policy statement that reflects both the commonality of the pandemic across the United States and the individual variability necessary at local sites. We issue this temporary statement as an interim stopgap opinion, pending a more thorough and considered process.COVID-19 and Cerebrovascular DiseaseAlthough 80% of patients infected with the virus remain nonhospitalized, in full form, COVID-19 is a severe acute respiratory syndrome caused by a novel coronavirus now named severe acute respiratory syndrome (SARS) CoV-2.1 In the past few weeks, it has become clear that patients infected with the SARS-CoV-2 virus may present in a number of ways, including with neurological symptoms that are coincident with, or could potentially precede, pulmonary symptoms and fever. To date, no comprehensive survey of neurological manifestations of coronavirus viremia has been published, but 2 retrospective case series have been posted without peer review on preprint servers. In these descriptions of convenience samples from 3 hospitals in Wuhan, China, up to 36% of COVID-19 patients manifest neurological symptoms.2,3 The most common neurological manifestations were dizziness (16.8%), headache (13.1%), and encephalopathy (2.8%). The most common peripheral signs and symptoms were anosmia (5.1%), dysgeusia (5.6%), and muscle injury (10.1%, detected by elevated creatine kinase). Stroke complicated COVID-19 infection in 5.9% of patients at median 10 days after symptom onset. Stroke patients were older, had more cardiovascular comorbidities, and more severe pneumonia. Stroke mechanisms may vary and could include hypercoagulability from critical illness and cardioembolism from virus-related cardiac injury.4 Some of these observations reflect the known biology of the virus, as the obligate receptor for the virus spike protein, human ACE2 (angiotensin-converting enzyme), is expressed in epithelial cells throughout the body, including in the central nervous system, raising the possibility of a direct role in viral infection.5 Other coronaviruses, including SARS-CoV-1 and MERS-CoV have been identified in the brains of patients (case reports) and heavily in the brains of mice that express human ACE2.6,7 However, at this time, there are no peer-reviewed published reports of clinical signs of SARS CoV-2 encephalitis or meningitis.ExigenciesWe seek to describe here the impact of the pandemic on the delivery of acute stroke treatment.Personal Protective EquipmentMost immediately, stroke teams may encounter difficulty responding to code strokes due to personal protective equipment (PPE) shortages in the Emergency Department (ED) and on inpatient units. In the ED, the patients with code stroke often arrives with limited available history and few or no family members or witnesses. Many patients with acute stroke are confused, aphasic, or otherwise unable to provide the necessary information for COVID-19 screening. Ideally, every patient with code stroke would be treated as potentially infected; the code stroke response team would do full PPE at the highest level. Such an approach is generally not possible, however.Stroke patients may have asymptomatic SARS-CoV-2 infection or develop COVID-19 after admission and treatment for stroke. Stroke patients frequently develop fevers due to other complications of stroke, such as aspiration pneumonia and urinary tract infection, and they will need to be evaluated quickly for COVID-19. These realities will stress the system even further.Stroke teams across the country have shared with us a variety of creative and novel solutions to the PPE shortage. Before sharing these with the stroke community, we feel compelled to vet them and seek permission to publish them. Over the coming days, we seek to post helpful solutions and suggestions. For example, some hospitals have partnered with local industry to create PPE with 3-dimensional Printers or repurposing of other technology to produce PPE items. We are aware that many teams have begun using telemedicine both within their own ED and regionally. This solution avoids the use of needed PPE, allows a reasonable stroke evaluation, avoids unnecessary inter-facility transfers, and reduces exposure risk for the stroke team.Hospital PersonnelEither through prophylactic quarantine or direct illness, most stroke teams will be forced to function with fewer staff members. Neurologists and other healthcare workers may be redeployed to other settings to respond to the increasing demands of COVID-19, particularly as other colleagues become ill. In some centers, ED staff are trained and competent to evaluate code strokes, and with stroke team guidance, to administer intravenous thrombolysis or transfer patients for possible mechanical thrombectomy. Some centers have nonstroke team staff available to monitor patients and arrange for post r-tPA or postthrombectomy care. In other centers, the loss of stroke team members may create a significant gap in care. We are aware of many stroke teams across the country expressing concern as to whether they can or will be able to continue to function.We think that all stroke teams should endeavor to adhere to all published guidelines regarding patient selection for therapy; treatment times (eg, door-to-needle and door-to-groin puncture); and postrecanalization monitoring. However, we wish to inform regulatory authorities—and we wish to reassure stroke teams—that in the setting of the pandemic full compliance has become a goal, not an expectation. Across the wide variety of healthcare delivery systems in our country, full compliance with all guidelines cannot happen at all times in every locality.We further wish to distinguish patient selection/treatment from logistic or process compliance. Patients who qualify for treatment will benefit, even if every single vital sign cannot be acquired post-thrombolysis, for example. Teams must use their judgement, guided by local realities, and continue to try to treat as many patients with acute stroke as possible.Hospital BedsMost, if not all, medical centers will likely fill all intensive care beds in the setting of COVID-19. Patients with large intracerebral hemorrhages, subarachnoid hemorrhage, or large ischemic strokes at risk for herniation must be monitored in intensive care unit settings with appropriately trained personnel, where possible. We are aware of situations in which NeuroICU beds may be requested for patients with COVID-19, to the exclusion of stroke patients. Although we recognize that hospitals and critical care administrators will need to prioritize ICU resources during the pandemic, we want to encourage appropriate resource allocation for critically ill stroke patients. In each locality specialists from all intensive care specialties—for example, pulmonary, cardiology, neurology, neurosurgery—must discuss the relative merits of prolonged ICU care for any particular patient.In the United States, stroke patients may be observed in an ICU setting for 24 hours after thrombolysis or thrombectomy, regardless of their status, with rigid intervals for regular vital signs and neurological assessments. There is no evidence base underlying this practice. In the absence of data supporting current practice, we suggest that it is feasible to move stable stroke patients to step-down or other units if an intensive care unit bed is needed.8In general, patients with intracerebral hemorrhage and subarachnoid hemorrhage have higher mortality and are more likely to undergo an interventional or surgical procedure and require intubation and prolonged time in an intensive care unit, compared with patients with ischemic stroke. Physicians and other healthcare personnel should follow the most up-to-date and evolving guidelines regarding intubation, interventional procedures, and critical care for these patients in setting of the pandemic. Appropriate intensive care of these seriously ill patients with hemorrhagic stroke, some of whom are also young and with an excellent long-term outcome, should be maintained.Finally, to protect staff, facilitate infectious disease evaluations, and conserve PPE, many hospitals have made the decision to admit all patients who are COVID-19 positive and those patients still under evaluation, regardless of other coincident disease, to specialized COVID-19 units. Many of the staff on these units will not have stroke care training. Stroke medical directors and coordinators should provide guidance to staff unfamiliar with managing patients with acute ischemic and hemorrhagic stroke.Emergency Medical ServicesWe are aware of anecdotal reports that stroke admission volumes have declined in some communities. This observation requires rigorous confirmation before we can offer sensible recommendations. If true, it can be asked whether the public anxiety around COVID-19 discourages some patients, especially those with mild stroke and stroke-mimics, from accessing the emergency medical services. A testable hypothesis would be that in the face of declining total stroke volume, there would persist a constant rate of moderate/severe stroke and thrombectomies. We therefore ask all participating stroke centers to contribute their data to the GWTG database vigilantly as this will be the simplest way to document any decrement in stroke volume. We also encourage stroke leaders and advocates to work with local media and public marketing to encourage patients to continue seeking emergency care if experiencing acute stroke symptoms.Provisional GuidanceWe can offer very limited guidance to stroke teams in the United States at this time. We do pledge to continue to collect your individual protocols and best practices and to evaluate and post them as appropriate. In very broad terms, we recommend the following.Guideline AdherenceContinue treating stroke patients as appropriate. Full adherence to guidelines may be challenging but needed treatment should be offered to the fullest extent possible https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000211.PPESeek ways to minimize the use of scarce PPE in your medical center. Send fewest possible team members to see patients with code stroke and into rooms for follow-up visits.TelemedicineTelemedicine began with telestroke. The National Institutes of Health Stroke Scale can be performed efficiently via telemedicine.9 Televideo is superior to telephone.10 Yet, telephonic consultation is superior to no consult.Health and SafetyTake care of yourselves, your families, and your teammates. Follow protocol (local, CDC, and WHO), including guidelines for hand washing, PPE use, COVID-19 testing and evaluation, and self-quarantine as needed.TeamworkStroke care has always been a multispecialty, collaborative effort among emergency medical services, physicians, and nurses from the EDs to the stroke units, ICUs, and rehabilitation centers. Collaboration, collegiality, and compassion for one another are crucial to making it through this challenge. A true sense of a unified stroke system of care is needed now more than ever.CaveatOur recommendations and anecdotal advice are offered to the general stroke community in the context of the gravest public health threat in our country's recent history. Nothing in this document has been submitted to the normal guideline development and peer review, although we will begin such a process immediately and update this statement continuously during the crisis. Please keep checking the American Heart Association/American Stroke Association website.DisclosuresNone.FootnotesCorrespondence to Patrick Lyden, MD, Department of Neurology, Cedars-Sinai Medical Center, 127 S San Vicente Medical Center, Los Angeles, CA 90048. Email lydenp@cshs.orgReferences1. Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19 — studies needed.New Engl J Med. 2020; 382:1194–1196. doi: 10.1056/NEJMp2002125Google Scholar2. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study.medRxiv. 2020; in press.Google Scholar3. Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study (3/3/2020).2020. Available at http://dx.doi.org/10.2139/ssrn.3550025Google Scholar4. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).JAMA Cardiol. 2020;e201017. doi: 10.1001/jamacardio.2020.1017Google Scholar5. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients.J Med Virol. 2020; in press.Google Scholar6. Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.bioRxiv. 2020; in press.Google Scholar7. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses.J Virol. 2000; 74:8913–8921. doi: 10.1128/jvi.74.19.8913-8921.2000Google Scholar8. Faigle R, Butler J, Carhuapoma JR, Johnson B, Zink EK, Shakes T, et al. Safety trial of low-intensity monitoring after thrombolysis: optimal post tpa-iv monitoring in ischemic stroke (OPTIMIST).Neurohospitalist. 2020; 10:11–15. doi: 10.1177/1941874419845229CrossrefGoogle Scholar9. Alasheev AM, Andreev AY, Gonysheva YV, Lagutenko MN, Lutskovich OY, Mamonova AV, et al. A comparison of remote and bedside assessment of the national institute of health stroke scale in acute stroke patients.Eur Neurol. 2017; 77:267–271. doi: 10.1159/000469706Google Scholar10. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study.Lancet Neurol. 2008; 7:787–795. doi: 10.1016/S1474-4422(08)70171-6CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Mallhi T, Safdar A, Butt M, Salman M, Nosheen S, Mustafa Z, Khan F and Khan Y (2024) Atypical Complications during the Course of COVID-19: A Comprehensive Review, Medicina, 10.3390/medicina60010164, 60:1, (164) Brosnan C, Brennan D, Reid C, Power S, O'Hare A, Brennan P, Thornton J and Crockett M (2023) The impact of the COVID-19 pandemic on the provision of endovascular thrombectomy for stroke: an Irish perspective, Irish Journal of Medical Science (1971 -), 10.1007/s11845-023-03314-9, 192:6, (3073-3079), Online publication date: 1-Dec-2023. Siegler J, Dasgupta S, Abdalkader M, Penckofer M, Yaghi S and Nguyen T (2023) Cerebrovascular Disease in COVID-19, Viruses, 10.3390/v15071598, 15:7, (1598) Sadiq A, Hassanali Z, Nziku E, Sadiq A and Dekker M (2023) Long COVID? Fatal case report of ischemic stroke and pulmonary embolism post COVID-19 infection, Radiology Case Reports, 10.1016/j.radcr.2023.02.022, 18:5, (1913-1917), Online publication date: 1-May-2023. Pérez-Neri I, Diéguez-Campa C, Tadger P, Sandoval H, Castillo-García V, Singh A, Carneiro da Costa C, Chaurasia B, Uy E and Ríos C (2023) Predictors of intrahospital mortality in patients with coronavirus disease 2019 and cerebrovascular diseases: rapid systematic review and meta-analysis protocol, Archivos de Neurociencias, 10.31157/an.v1iInpress.441 Almhdawi K, Jaber H, Alghwiri A, Arabiat A, Alazrai A, Tariah H, Obeidat D and Alrabbaie H (2021) Health-related quality of life and its correlates among individuals with stroke during the COVID-19 pandemic, Neuropsychological Rehabilitation, 10.1080/09602011.2021.1984256, 33:1, (69-84), Online publication date: 2-Jan-2023. Suri V, Suri K and Suri K (2023) Antiplatelets in Acute Management and Prevention of Transient Ischemic Attack and Stroke, Apollo Medicine, 10.4103/am.am_124_22, 20:4, (365-370), . Pensato U, Romoli M, Lazzarin S, Marcheselli S and Zini A (2023) The shortage of thrombolytics for stroke: a call for action, The Lancet Neurology, 10.1016/S1474-4422(22)00477-X, 22:1, (28), Online publication date: 1-Jan-2023. BAYDEMİR R, ASLANER H, KALIN ÜNÜVAR G, GÜLTEKİN M, BENLİ Ş and BENLİ A (2022) Evaluation of Stroke Frequency in COVID-19 PatientsCOVID-19 Hastalarında İnme Sıklığının Değerlendirilmesi, Online Türk Sağlık Bilimleri Dergisi, 10.26453/otjhs.1065835, 7:4, (546-552) Sandberg C, Niemkiewicz J, Kubat A and Conyers L (2022) Impact of COVID-19 on People With Aphasia: Emerging Rehabilitation Needs, Rehabilitation Research, Policy, and Education, 10.1891/RE-21-23, 36:4, (264-275), Online publication date: 1-Dec-2022. Jin Y, Cui H, Chen L, Liu Z and Sun K (2022) Study of the flow mechanism and influencing factors of sputum excretion from the distal lung, International Journal of Numerical Methods for Heat & Fluid Flow, 10.1108/HFF-02-2022-0095, 32:12, (3782-3799), Online publication date: 25-Nov-2022. Zha A, Sharrief A, Czap A, Liebeskind D, Vora N, Rai V, Desai S, Jadhav A, Infante I, Starosciak A, Hassan A, Farooqui M, Ortega‐Gutierrez S, Jillella D, Mohammaden M, Haussen D, Nogueira R, Nguyen T, Abdalkader M, Khandelwal P, Zaidat O, Higham C, Heslin M, Jovin T and Siegler J (2022) Short‐Term Outcomes of Acute Stroke During COVID‐19 by Race and Ethnicity in the United States: The Society of Vascular and Interventional Neurology Multicenter Collaboration, Stroke: Vascular and Interventional Neurology, 2:6, Online publication date: 1-Nov-2022. Harahsheh E, English S, Hrdlicka C and Demaerschalk B (2022) Telestroke's Role Through the COVID-19 Pandemic and Beyond, Current Treatment Options in Neurology, 10.1007/s11940-022-00737-0, 24:11, (589-603), Online publication date: 1-Nov-2022. Miller E, Stacy K and Bakas T (2022) Stroke Family Caregiver Life Changes From the COVID-19 Pandemic, Journal of Neuroscience Nursing, 10.1097/JNN.0000000000000654, 54:4, (159-164), Online publication date: 1-Aug-2022. Siegler J, Abdalkader M, Michel P and Nguyen T (2022) Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future Perspectives, Journal of Stroke, 10.5853/jos.2022.00843, 24:2, (179-188), Online publication date: 31-May-2022. Stephenson A, Howes S, Murphy P, Deutsch J, Stokes M, Pedlow K, McDonough S and Javadi A (2022) Factors influencing the delivery of telerehabilitation for stroke: A systematic review, PLOS ONE, 10.1371/journal.pone.0265828, 17:5, (e0265828) Duan Y, Shammassian B, Srivatsa S, Sunshine K, Chugh A, Pace J, Opaskar A and Bambakidis N Bypassing the intensive care unit for patients with acute ischemic stroke secondary to large-vessel occlusion, Journal of Neurosurgery, 10.3171/2021.6.JNS21308, 136:5, (1240-1244) Miller E and Hinkle J (2022) Nursing's Contributions to Stroke Care During COVID-19, Stroke, 53:4, (1396-1398), Online publication date: 1-Apr-2022. Gonzalez F, Caiza Zambrano F, Bala M, Saucedo M, Bandeo L, León Cejas L, Uribe Roca C, Bottaro F, Fernández Pardal M, Reisin R and Bonardo P (2022) A un año de la pandemia en Argentina, características clínicas de pacientes con accidente cerebral agudo en una cohorte hospitalaria y sus implicancias, Neurología Argentina, 10.1016/j.neuarg.2021.10.001, 14:2, (85-91), Online publication date: 1-Apr-2022. Long B, Carius B, Chavez S, Liang S, Brady W, Koyfman A and Gottlieb M (2022) Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation, The American Journal of Emergency Medicine, 10.1016/j.ajem.2022.01.028, 54, (46-57), Online publication date: 1-Apr-2022. Simonetto M, Wechsler P and Merkler A (2022) Stroke Treatment in the Era of COVID-19: a Review, Current Treatment Options in Neurology, 10.1007/s11940-022-00713-8, 24:4, (155-171), Online publication date: 1-Apr-2022. de Lange M, Carvalho A, Brito Fernandes Ó, Lingsma H, Klazinga N and Kringos D (2022) The Impact of the COVID-19 Pandemic on Hospital Services for Patients with Cardiac Diseases: A Scoping Review, International Journal of Environmental Research and Public Health, 10.3390/ijerph19063172, 19:6, (3172) Pandain J, Panagos P, Sebastian I, Silva G, Furie K, Liu L, Owolabi M, Caso V and Alrukn S (2022) Maintaining Stroke Care During the COVID-19 Pandemic in Lower- and Middle-Income Countries: World Stroke Organization Position Statement Endorsed by American Stroke Association and American Heart Association, Stroke, 53:3, (1043-1050), Online publication date: 1-Mar-2022. Atchie B, Jarvis S, Stoddard E, Salottolo K, Nieberlein A, McCarthy K, Bartt R, Bennett A, Burrell C, Frei D and Bar-Or D (2021) Implementing the SNIS recommendations for neurointerventional emergent care in the setting of COVID-19: impact on stroke metrics and patient outcomes, Journal of NeuroInterventional Surgery, 10.1136/neurintsurg-2021-017415, 14:3, (268-273), Online publication date: 1-Mar-2022. Preobrazhenskaya I (2022) COVID-associated cognitive impairments: A review, Consilium Medicum, 10.26442/20751753.2022.2.201512, 24:2, (96-102) Chen N, Wu X, Zhou M, Yang R, Chen D, Liao M, Deng Y, Hong Z, Zhou D and He L (2022) Telestroke for the Treatment of Ischemic Stroke in Western China During the COVID-19 Pandemic: A Multicenter Observational Study, Frontiers in Neurology, 10.3389/fneur.2021.822342, 12 Rubakova A, Lebedeva J, Turovina E, I S, Khasanova L, Suvorov A and Kazakova Z (2022) Clinical and pathophysiological features of stroke in patients with COVID-19, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 10.17116/jnevro202212212226, 122:12, (26), . Castillo-Pinto C, Lamotte G, Mehta A, Sonti R, Di Maria G, Ruiz D, Kumar P, Stemer A and Denny M (2020) Healthcare Worker With Large Vessel Acute Ischemic Stroke Likely Related to Mild SARS-CoV-2 Infection, The Neurohospitalist, 10.1177/1941874420966845, 12:1, (48-56), Online publication date: 1-Jan-2022. Pandian J, Panagos P, Sebastian I, Sampaio Silva G, Furie K, Liu L, Owolabi M, Caso V and Alrukn S (2021) Maintaining stroke care during the COVID-19 pandemic in lower- and middle-income countries: World Stroke Organization Position Statement endorsed by American Stroke Association and American Heart Association, International Journal of Stroke, 10.1177/17474930211055878, 17:1, (9-17), Online publication date: 1-Jan-2022. Al Qawasmeh M, Ahmed Y, Nsour O, Qarqash A, Al-Horani S, Hazaimeh E, Jbarah O, Yassin A, Aldabbour B, Alhusban A and El-Salem K (2022)(2022) Functional outcomes of COVID-19 patients with acute ischemic stroke: A prospective, observational, single-center study in North Jordan, Medicine, 10.1097/MD.0000000000029834, 101:26, (e29834) Cicek M, Onalan M and Yurtseven N (2021) COVID-19 and ECMO support after neonatal congenital heart surgery: a case report, Cardiology in the Young, 10.1017/S1047951121002511, 32:1, (150-153), Online publication date: 1-Jan-2022. Qureshi A, Baskett W, Huang W, Ishfaq M, Naqvi S, French B, Siddiq F, Gomez C and Shyu C (2022) Utilization and Outcomes of Acute Revascularization Treatments in Ischemic Stroke Patients with SARS-CoV-2 Infection, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2021.106157, 31:1, (106157), Online publication date: 1-Jan-2022. Lancheros Pineda L, Yasno Arias D, Zea Rojas D, Torres Ballesteros V and Bernal Pacheco O (2021) Manifestaciones neurológicas por COVID-19. Reporte de casos en Hospital Militar Central Bogotá, Colombia, y revisión de la literatura, Revista Med, 10.18359/rmed.5144, 29:1, (57-76) Pfaff J, Harlan M, Pfaff G, Hubert A and Bendszus M (2021) Neuroradiological emergency consultations during the first year of the COVID-19 pandemic, Neurological Research and Practice, 10.1186/s42466-021-00147-8, 3:1, Online publication date: 1-Dec-2021. Yassin A, Nawaiseh M, Shaban A, Alsherbini K, El-Salem K, Soudah O and Abu-Rub M (2021) Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis, BMC Neurology, 10.1186/s12883-021-02161-4, 21:1, Online publication date: 1-Dec-2021. Martí-Fàbregas J, Guisado-Alonso D, Delgado-Mederos R, Martínez-Domeño A, Prats-Sánchez L, Guasch-Jiménez M, Cardona P, Núñez-Guillén A, Requena M, Rubiera M, Olivé M, Bustamante A, Gomis M, Amaro S, Llull L, Ustrell X, Castilho de Oliveira G, Seró L, Gomez-Choco M, Mena L, Serena J, Bashir Viturro S, Purroy F, Vicente M, Rodríguez-Campello A, Ois A, Catena E, Carmen Garcia-Carreira M, Barrachina O, Palomeras E, Krupinski J, Almeria M, Zaragoza J, Esteve P, Cocho D, Moreira A, van Eendenburg C, Emilio Codas J, Pérez de la Ossa N, Salvat M and Camps-Renom P (2021) Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke, Stroke, 52:12, (3908-3917), Online publication date: 1-Dec-2021. Fuentes B, Alonso de Leciñana M, Rigual R, García‐Madrona S, Díaz‐Otero F, Aguirre C, Calleja P, Egido‐Herrero J, Carneado‐Ruiz J, Ruiz‐Ares G, Rodríguez‐Pardo J, Rodríguez‐López Á, Ximénez‐Carrillo Á, de Felipe A, Ostos F, González‐Ortega G, Simal P, Gómez Escalonilla C, Gómez‐Porro‐Sánchez P, Cabal‐Paz B, Reig G, Gil‐Núñez A, Masjuán J and Díez Tejedor E (2021) Fewer COVID‐19‐associated strokes and reduced severity during the second COVID‐19 wave: The Madrid Stroke Network, European Journal of Neurology, 10.1111/ene.15112, 28:12, (4078-4089), Online publication date: 1-Dec-2021. Ko S, Nguyen N, Lee C, Lee L, Nguyen K and Lee E Aeromedical Implications of Long-Term COVID-19 Sequelae, Aerospace Medicine and Human Performance, 10.3357/AMHP.5928.2021, 92:11, (898-907) Yang Q, Tong X, Coleman King S, Olivari B and Merritt R (2021) Stroke Hospitalizations Before and During COVID-19 Pandemic Among Medicare Beneficiaries in the United States, Stroke, 52:11, (3586-3601), Online publication date: 1-Nov-2021. Wu Y, Chen F, Sun Z, Zhang Y, Song Y, Feng W, Wang Y, Liu Y and Song H (2021) Impact of the pandemic of COVID-19 on emergency attendance for stroke and acute myocardial infarction in Beijing, China, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-021-02385-8, 52:4, (1047-1055), Online publication date: 1-Nov-2021. Azimov A, Rakhimbaeva G and Azimov F (2021) Anticoagulant therapy for stroke prevention in patients with severe COVID-19, Neurology, Neuropsychiatry, Psychosomatics, 10.14412/2074-2711-2021-5-20-25, 13:5, (20-25) KALAV S and BOYRAZ S (2021) Yeni Koronavirüs Hastalığı Pandemisinde Akut İskemik İnmede Hemşirelik Bakımının YönetimiManagement of Nursing Care in Acute Ischemic Stroke in the Novel Coronavirus Disease Pandemic, Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi, 10.46483/deuhfed.886004, 14:4, (453-460) Peng G, Nie X, Liebeskind D, Liu L and Miao Z (2021) Management of endovascular therapy for acute ischemic stroke amid the COVID-2019 pandemic: a multicenter survey in China, Neurological Research, 10.1080/01616412.2021.1939236, 43:10, (823-830), Online publication date: 3-Oct-2021. Leslie-Mazwi T and Srivatanakul K (2021) Coronavirus disease 2019 and stroke, Interventional Neuroradiology, 10.1177/15910199211035920, 27:1_suppl, (13-18), Online publication date: 1-Oct-2021. Srivastava P, Zhang S, Xian Y, Xu H, Rutan C, Alger H, Walchok J, Williams J, de Lemos J, Decker-Palmer M, Alhanti B, Elkind M, Messé S, Smith E, Schwamm L and Fonarow G (2021) Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19, Stroke, 52:10, (3225-3232), Online publication date: 1-Oct-2021. Padjen V (2021) Acute stroke care during the COVID‐19 pandemic, European Journal of Neurology, 10.1111/ene.14843, 28:10, (
Referência(s)